152 related articles for article (PubMed ID: 32954379)
21. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
[TBL] [Abstract][Full Text] [Related]
22. Quantification of blood-to-brain transfer rate in multiple sclerosis.
Taheri S; Rosenberg GA; Ford C
Mult Scler Relat Disord; 2013 Apr; 2(2):124-32. PubMed ID: 25877634
[TBL] [Abstract][Full Text] [Related]
23. The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS.
Pardini M; Petracca M; Harel A; Fleysher L; Oesingmann N; Bommarito G; Fabian M; Chard D; Lublin F; Inglese M
Neuroimage Clin; 2017; 16():111-115. PubMed ID: 28794971
[TBL] [Abstract][Full Text] [Related]
24. Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
Sweeney EM; Shinohara RT; Dewey BE; Schindler MK; Muschelli J; Reich DS; Crainiceanu CM; Eloyan A
Neuroimage Clin; 2016; 10():1-17. PubMed ID: 26693397
[TBL] [Abstract][Full Text] [Related]
25. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
[TBL] [Abstract][Full Text] [Related]
26. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
[TBL] [Abstract][Full Text] [Related]
27. Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study.
Vellinga MM; Vrenken H; Hulst HE; Polman CH; Uitdehaag BM; Pouwels PJ; Barkhof F; Geurts JJ
J Magn Reson Imaging; 2009 Apr; 29(4):774-9. PubMed ID: 19306366
[TBL] [Abstract][Full Text] [Related]
28. A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
Sethi V; Yousry T; Muhlert N; Tozer DJ; Altmann D; Ron M; Wheeler-Kingshott C; Miller DH; Chard DT
J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):750-3. PubMed ID: 26272028
[TBL] [Abstract][Full Text] [Related]
29. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
[TBL] [Abstract][Full Text] [Related]
30. Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.
Chen W; Zhang Y; Mu K; Pan C; Gauthier SA; Zhu W; Wang Y
AJR Am J Roentgenol; 2017 Oct; 209(4):889-894. PubMed ID: 28705068
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis.
Zeis T; Howell OW; Reynolds R; Schaeren-Wiemers N
Exp Neurol; 2018 Jul; 305():76-88. PubMed ID: 29596844
[TBL] [Abstract][Full Text] [Related]
32. Automated Detection and Segmentation of Multiple Sclerosis Lesions Using Ultra-High-Field MP2RAGE.
Fartaria MJ; Sati P; Todea A; Radue EW; Rahmanzadeh R; OʼBrien K; Reich DS; Bach Cuadra M; Kober T; Granziera C
Invest Radiol; 2019 Jun; 54(6):356-364. PubMed ID: 30829941
[TBL] [Abstract][Full Text] [Related]
33. Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study.
Margoni M; Petracca M; Schiavi S; Fabian M; Miller A; Lublin FD; Inglese M
Eur J Neurol; 2019 Aug; 26(8):1068-1074. PubMed ID: 30761708
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study.
Vercellino M; Trebini C; Capello E; Mancardi GL; Giordana MT; Cavalla P
J Neuroimmunol; 2017 Nov; 312():49-58. PubMed ID: 28919237
[TBL] [Abstract][Full Text] [Related]
35. The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis.
Ma AY; Vitorino RC; Hojjat SP; Mulholland AD; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI
Mult Scler; 2017 Dec; 23(14):1884-1892. PubMed ID: 28178867
[TBL] [Abstract][Full Text] [Related]
36. Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study.
Jonkman LE; Soriano AL; Amor S; Barkhof F; van der Valk P; Vrenken H; Geurts JJ
J Neurol; 2015; 262(4):1074-80. PubMed ID: 25761376
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome analysis of normal-appearing white matter reveals cortisol- and disease-associated gene expression profiles in multiple sclerosis.
Melief J; Orre M; Bossers K; van Eden CG; Schuurman KG; Mason MRJ; Verhaagen J; Hamann J; Huitinga I
Acta Neuropathol Commun; 2019 Apr; 7(1):60. PubMed ID: 31023360
[TBL] [Abstract][Full Text] [Related]
38. What explains gray matter atrophy in long-standing multiple sclerosis?
Steenwijk MD; Daams M; Pouwels PJ; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
[TBL] [Abstract][Full Text] [Related]
39. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis.
Ge Y; Grossman RI; Udupa JK; Babb JS; Mannon LJ; McGowan JC
J Comput Assist Tomogr; 2002; 26(1):62-8. PubMed ID: 11801905
[TBL] [Abstract][Full Text] [Related]
40. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
Pietroboni AM; Carandini T; Colombi A; Mercurio M; Ghezzi L; Giulietti G; Scarioni M; Arighi A; Fenoglio C; De Riz MA; Fumagalli GG; Basilico P; Serpente M; Bozzali M; Scarpini E; Galimberti D; Marotta G
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
